Discontinued — last reported Q2 '22
Short-Term Borrowings
ResMed Short-Term Borrowings increased by 0.0% to $259.93M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2523.9%, from $9.91M to $259.93M. Over 4 years (FY 2021 to FY 2025), Short-Term Borrowings shows a downward trend with a -4.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Detailed definition
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Peer comparison
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowingsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.00M | $12.00M | $12.00M | $11.97M | $9.92M | $9.91M | $9.90M | $9.90M | $9.90M | $9.91M | $9.90M | $9.90M | $9.90M | $9.90M | $9.91M | $9.91M | $9.90M | $259.90M | $259.91M | $259.93M |
| QoQ Change | — | +0.0% | +0.0% | -0.3% | -17.1% | -0.1% | -0.1% | +0.0% | +0.0% | +0.0% | -0.1% | +0.1% | -0.0% | -0.0% | +0.1% | +0.0% | -0.1% | >999% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -17.4% | -17.4% | -17.5% | -17.3% | -0.1% | -0.0% | -0.0% | +0.0% | -0.0% | -0.1% | +0.1% | +0.0% | +0.0% | >999% | >999% | >999% |
Short-Term Borrowings at Other Companies
Frequently Asked Questions
- What is ResMed's short-term borrowings?
- ResMed (RMD) reported short-term borrowings of $259.93M in Q1 2026.
- How has ResMed's short-term borrowings changed year-over-year?
- ResMed's short-term borrowings increased by 2523.9% year-over-year, from $9.91M to $259.93M.
- What is the long-term trend for ResMed's short-term borrowings?
- Over 4 years (2021 to 2025), ResMed's short-term borrowings has grown at a -4.7% compound annual growth rate (CAGR), from $12.00M to $9.90M.
- What does short-term borrowings mean?
- Debt that must be repaid within the next twelve months.